Press Release

Enteric Disease Testing Market to grow with a CAGR of 4.69% through 2029

Increasing healthcare infrastructure and a supportive regulatory environment are the major drivers for the Global Enteric Disease Testing Market during the forecast period 2025-2029

 

According to TechSci Research report, “Enteric Disease Testing Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2019-2029”, Global Enteric Disease Testing Market has valued at USD 3.98 billion in 2023 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 4.69% through 2029.

Collaborations and partnerships among leading companies are instrumental in consolidating expertise and bolstering market presence. Increased awareness significantly propels the demand for enteric disease testing. Heightened consciousness about health and wellness prompts individuals to seek medical advice and diagnostic testing upon experiencing symptoms of enteric diseases. The public's growing awareness of food safety issues, including foodborne illnesses, is fueled by high-profile outbreaks and recalls, prompting individuals to advocate for rigorous testing of food products. Media coverage of enteric disease outbreaks, food recalls, and public health campaigns further amplifies awareness, emphasizing the importance of health and safety. Access to information online enables individuals to educate themselves about enteric disease symptoms and risks, fostering a greater understanding of the need for testing when experiencing gastrointestinal symptoms. Healthcare providers, sensitized by awareness campaigns and educational efforts, are more inclined to recommend enteric disease testing when deemed necessary, as patients become increasingly aware of its significance.

 

Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " Global Enteric Disease Testing Market

 

The expense associated with enteric disease testing presents a notable challenge in the global market, impacting various stakeholders including healthcare providers, patients, and public health systems. Testing costs can serve as a deterrent for individuals seeking healthcare services, particularly in regions with limited access to affordable healthcare. Disparities in testing access can result in healthcare inequalities, as those with limited financial means may encounter difficulties in obtaining necessary testing, potentially leading to delays in diagnosis and treatment. Healthcare systems and governments are required to allocate funds for diagnostic testing programs, which can strain budgets and resources, particularly in areas with a high prevalence of enteric diseases. The establishment and maintenance of diagnostic infrastructure, such as clinical laboratories and point-of-care testing facilities, entail significant financial investments. In resource-constrained settings where enteric diseases are prevalent, testing costs pose a substantial barrier to implementing robust diagnostic initiatives, potentially impeding early detection and treatment.


Global Enteric Disease Testing Market is segmented based on Disease Type, End User, and by region.

Based on end user, the Global Enteric Disease Testing Market largest share was held by Hospitals & Clinics segment in the forecast period and is predicted to continue expanding over the coming years.  Hospitals and clinics serve as primary points of access to healthcare services for individuals with enteric disease symptoms. Patients often seek initial diagnosis and treatment at these facilities, which drives the demand for enteric disease testing. Hospitals and clinics offer a wide range of medical services, including diagnostics, treatment, and patient care. This makes them well-suited to provide comprehensive enteric disease testing as part of their broader healthcare offerings. Hospitals are equipped to handle severe cases of enteric diseases that require emergency care. Clinics can also address moderate to severe cases. Testing is vital in these settings to guide treatment decisions. Many hospitals have specialized departments, such as gastroenterology and infectious disease units, that focus on the diagnosis and treatment of enteric diseases. These departments frequently conduct extensive testing to identify specific pathogens causing gastrointestinal issues. Hospitals and clinics typically have experienced medical professionals and access to advanced diagnostic technologies. This expertise ensures accurate and timely diagnosis of enteric diseases. Hospitals provide both inpatient and outpatient care, offering testing services for various patient needs, from routine outpatient screening to more complex inpatient cases.

Based on Region, North America held the largest share in the Global Enteric Disease Testing Market. The well-established private healthcare sector in North America incentivizes investments in diagnostic technologies and enhances access to testing services for individuals with private insurance coverage. Healthcare providers in the region benefit from access to state-of-the-art diagnostic resources, including molecular diagnostics, high-throughput testing, and automated systems. North America's robust capacity for epidemiological surveillance facilitates the prompt identification and containment of enteric disease outbreaks. The insurance and reimbursement frameworks, particularly in the United States, support the utilization of diagnostic tests, simplifying access for patients in need. Intense competition within North America's healthcare landscape drives ongoing innovation and market expansion as companies compete for market share and strive to introduce new and enhanced enteric disease testing solutions.

 

Some of the major companies operating in the Global Enteric Disease Testing Market include:

  • Abbott Laboratories Ltd.
  • Beckton Dickinson & Co.
  • Biomerica Inc.
  • BIOMÉRIEUX SA
  • Bio-Rad Laboratories, Inc.
  • Cepheid
  • Coris BioConcept
  • DiaSorin S.p.A.
  • Meridian Bioscience Inc.
  • Quest Diagnostics Incorporated

 

Download Free Sample Report

Customers can also request for 10% free customization on this report

 

“In the enteric disease testing market, growth prospects are strong as market players in healthcare, food safety, and environmental sectors prioritize strategies to prevent, diagnose, and manage enteric diseases. Sustained investment in research and development, alongside partnerships among public health agencies, diagnostic manufacturers, and regulatory authorities, will be crucial to tackle evolving challenges and fulfill the rising need for precise and prompt enteric disease testing solutions.," said Mr. Karan Chechi, Research Director of TechSci Research, a research-based Global management consulting firm.

"Enteric Disease Testing Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (Bacterial Enteric Diseases, Viral Enteric Diseases, Parasitic Enteric Diseases, Rotavirus, Norovirus), End User (Hospitals & Clinics, Diagnostic Centers, Others), by region, and Competition, 2019-2029Fhas evaluated the future growth potential of Global Enteric Disease Testing Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Enteric Disease Testing Market.

 

Contact

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +13322586602

Email: [email protected]

Website: www.techsciresearch.com

Relevant News